David Happel
President & CEO at Sagimet Biosciences Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Sagimet Biosciences Inc., 3 years.
Sagimet Biosciences Inc.
Director · President & CEO
Chief executive roles
Sagimet Biosciences Inc.
· President & CEO
Since July 2023
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2024 | Sagimet Biosciences Inc. | Open-market purchase | +12,100 | $5.27 | $63,767 |
| Dec 7, 2023 | Sagimet Biosciences Inc. | Open-market purchase | +1,600 | $4.10 | $6,560 |
| Nov 17, 2023 | Sagimet Biosciences Inc. | Grant or award | +624,910 | — | — |
| Nov 16, 2023 | Sagimet Biosciences Inc. | Open-market purchase | +590 | $2.35 | $1,387 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.